<DOC>
	<DOCNO>NCT02982876</DOCNO>
	<brief_summary>Silicone stent use standard care identify patient excessive dynamic airway collapse benefit definitive surgical treatment . However , specific way stent effective test . The purpose research study determine effectiveness silicone stent use airways patient severe symptomatic excessive dynamic airway collapse compare patient severe symptomatic excessive dynamic airway collapse receive silicone stent .</brief_summary>
	<brief_title>Silicone Airway Stents Excessive Dynamic Airway Collapse : A Randomized Placebo Controlled Double-Blinded Trial</brief_title>
	<detailed_description>Study Design This randomized placebo control double-blinded trial conduct Beth Israel Deaconess Medical Center ( BIDMC ) accordance Good Clinical Practice Standards IRB supervision . We plan enroll total 60 patient EDAC randomize computer generate system either intervention group ( Silicone Stent ) Placebo group ( Sham Procedure ) . Description study Previous appointment patient Airway CT scan , 6 minute walk test pulmonary function test per protocol standard care . Enrollment Patients severe EDAC remain symptomatic despite optimal medical management inform trial interested recruit study . Operative Technique All patient undergo dynamic flexible bronchoscopy light sedation rigid bronchoscopy general anesthesia . The treatment group undergo bronchial wash placement Y-silicone stent . Silicone stent Based patient 's airway anatomy endotracheal Dumon Y silicone stent ( Endoxane , Novatech S.A. , Aubagne-France ) Channick Y silicone stent ( Hood Laboratories , Pembroke , MA , 02359 ) use study . Both option make silicone histocompatible tracheal bronchial tissue . These device FDA approve benign airway disease tracheobronchomalacia . During Stent Trial After bronchoscopy patient intervention placebo arm receive standardize protocol use mucolytic expectorant ( nebulizer treatment use mucolytic ( N-acetylcysteine ) 15 minute BID , Guafenesin ( MucinexÂ® ) 1200 mg BID , codeine need Flutter valve BID ) blind health provide . Follow-up The patient schedule follow-up visit next 7-10 day rigid bronchoscopy outpatient clinic , 6MWTs PFTs . The outcome measure patient ( placebo treatment group ) un-blinded . Stent removal The patient schedule , 14 day stent insertion , removal operating room .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Tracheobronchomalacia</mesh_term>
	<criteria>Patient sever symptomatic EDAC ( collapse &gt; 90 % airway exhalation dynamic CT scan ) Age &gt; 18 year Patients well manage respiratory comorbidities ( asthma , COPD , obstruct sleep apnea , GERD , relapse polychondritis ) Current respiratory infection Resting bradycardia ( &lt; 50 beats/min ) , frequent multifocal PVCs , complex ventricular arrhythmia , sustain SVT Dysrhythmia might pose risk exercise training Any disease condition interfere completion initial followup assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Silicone Airway stent</keyword>
</DOC>